vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and Sezzle Inc. (SEZL). Click either name above to swap in a different company.

Sezzle Inc. is the larger business by last-quarter revenue ($78.2M vs $75.5M, roughly 1.0× PUMA BIOTECHNOLOGY, INC.). On growth, Sezzle Inc. posted the faster year-over-year revenue change (61.6% vs 27.7%). Sezzle Inc. produced more free cash flow last quarter ($70.6M vs $14.4M). Over the past eight quarters, Sezzle Inc.'s revenue compounded faster (76.0% CAGR vs 31.3%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Sezzle is a publicly traded financial technology company headquartered in Minneapolis, U.S, with operations in the United States and Canada. The company provides an alternative payment platform offering interest-free installment plans at selected online stores. As of June 2021, the Sezzle platform had over 10 million user sign-ups and over 48,000 participating merchants.

PBYI vs SEZL — Head-to-Head

Bigger by revenue
SEZL
SEZL
1.0× larger
SEZL
$78.2M
$75.5M
PBYI
Growing faster (revenue YoY)
SEZL
SEZL
+33.9% gap
SEZL
61.6%
27.7%
PBYI
More free cash flow
SEZL
SEZL
$56.2M more FCF
SEZL
$70.6M
$14.4M
PBYI
Faster 2-yr revenue CAGR
SEZL
SEZL
Annualised
SEZL
76.0%
31.3%
PBYI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBYI
PBYI
SEZL
SEZL
Revenue
$75.5M
$78.2M
Net Profit
$42.7M
Gross Margin
69.3%
Operating Margin
22.7%
70.6%
Net Margin
54.6%
Revenue YoY
27.7%
61.6%
Net Profit YoY
68.3%
EPS (diluted)
$0.26
$1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
SEZL
SEZL
Q4 25
$75.5M
$78.2M
Q3 25
$54.5M
$57.5M
Q2 25
$52.4M
$52.0M
Q1 25
$46.0M
$48.2M
Q4 24
$59.1M
$48.4M
Q3 24
$80.5M
$35.6M
Q2 24
$47.1M
$30.2M
Q1 24
$43.8M
$25.2M
Net Profit
PBYI
PBYI
SEZL
SEZL
Q4 25
$42.7M
Q3 25
$8.8M
$26.7M
Q2 25
$5.9M
$27.6M
Q1 25
$3.0M
$36.2M
Q4 24
$25.4M
Q3 24
$20.3M
$15.4M
Q2 24
$-4.5M
$29.7M
Q1 24
$-4.8M
$8.0M
Gross Margin
PBYI
PBYI
SEZL
SEZL
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
PBYI
PBYI
SEZL
SEZL
Q4 25
22.7%
70.6%
Q3 25
17.6%
61.9%
Q2 25
12.7%
69.4%
Q1 25
8.7%
Q4 24
22.6%
63.8%
Q3 24
27.4%
58.6%
Q2 24
-4.6%
55.3%
Q1 24
-5.3%
54.8%
Net Margin
PBYI
PBYI
SEZL
SEZL
Q4 25
54.6%
Q3 25
16.2%
46.4%
Q2 25
11.2%
53.1%
Q1 25
6.5%
75.1%
Q4 24
52.4%
Q3 24
25.2%
43.4%
Q2 24
-9.6%
98.4%
Q1 24
-11.0%
31.7%
EPS (diluted)
PBYI
PBYI
SEZL
SEZL
Q4 25
$0.26
$1.19
Q3 25
$0.17
$0.75
Q2 25
$0.12
$0.78
Q1 25
$0.06
$1.00
Q4 24
$0.40
$0.71
Q3 24
$0.41
$0.44
Q2 24
$-0.09
$0.82
Q1 24
$-0.10
$0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
SEZL
SEZL
Cash + ST InvestmentsLiquidity on hand
$97.5M
$64.1M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$130.3M
$169.8M
Total Assets
$216.3M
$400.2M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
SEZL
SEZL
Q4 25
$97.5M
$64.1M
Q3 25
$94.4M
$104.1M
Q2 25
$96.0M
$88.9M
Q1 25
$93.2M
$88.9M
Q4 24
$101.0M
$73.2M
Q3 24
$96.7M
$80.1M
Q2 24
$96.8M
$58.0M
Q1 24
$107.2M
$77.8M
Total Debt
PBYI
PBYI
SEZL
SEZL
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
PBYI
PBYI
SEZL
SEZL
Q4 25
$130.3M
$169.8M
Q3 25
$115.3M
$155.3M
Q2 25
$104.7M
$130.4M
Q1 25
$97.1M
$125.8M
Q4 24
$92.1M
$87.8M
Q3 24
$71.1M
$61.1M
Q2 24
$48.5M
$50.3M
Q1 24
$51.0M
$29.6M
Total Assets
PBYI
PBYI
SEZL
SEZL
Q4 25
$216.3M
$400.2M
Q3 25
$202.9M
$367.0M
Q2 25
$194.9M
$350.6M
Q1 25
$196.2M
$298.1M
Q4 24
$213.3M
$298.4M
Q3 24
$220.7M
$252.9M
Q2 24
$205.0M
$212.1M
Q1 24
$214.1M
$195.7M
Debt / Equity
PBYI
PBYI
SEZL
SEZL
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
SEZL
SEZL
Operating Cash FlowLast quarter
$14.4M
$70.6M
Free Cash FlowOCF − Capex
$14.4M
$70.6M
FCF MarginFCF / Revenue
19.1%
90.2%
Capex IntensityCapex / Revenue
0.0%
0.1%
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters
$41.7M
$209.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
SEZL
SEZL
Q4 25
$14.4M
$70.6M
Q3 25
$9.7M
$63.7M
Q2 25
$14.1M
$23.1M
Q1 25
$3.6M
$52.5M
Q4 24
$15.6M
$57.4M
Q3 24
$11.0M
$35.1M
Q2 24
$1.0M
$22.2M
Q1 24
$11.2M
$16.0M
Free Cash Flow
PBYI
PBYI
SEZL
SEZL
Q4 25
$14.4M
$70.6M
Q3 25
$9.7M
$63.6M
Q2 25
$14.1M
$22.7M
Q1 25
$3.6M
$52.5M
Q4 24
$15.6M
$57.4M
Q3 24
$11.0M
$35.1M
Q2 24
$1.0M
$22.2M
Q1 24
$16.0M
FCF Margin
PBYI
PBYI
SEZL
SEZL
Q4 25
19.1%
90.2%
Q3 25
17.7%
110.6%
Q2 25
26.8%
43.6%
Q1 25
7.7%
108.9%
Q4 24
26.4%
118.5%
Q3 24
13.7%
98.6%
Q2 24
2.1%
73.4%
Q1 24
63.3%
Capex Intensity
PBYI
PBYI
SEZL
SEZL
Q4 25
0.0%
0.1%
Q3 25
0.0%
0.3%
Q2 25
0.0%
0.8%
Q1 25
0.1%
0.1%
Q4 24
0.0%
0.1%
Q3 24
0.0%
0.0%
Q2 24
0.0%
0.1%
Q1 24
0.0%
0.0%
Cash Conversion
PBYI
PBYI
SEZL
SEZL
Q4 25
1.65×
Q3 25
1.10×
2.39×
Q2 25
2.41×
0.84×
Q1 25
1.21×
1.45×
Q4 24
2.26×
Q3 24
0.54×
2.27×
Q2 24
0.75×
Q1 24
2.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PBYI
PBYI

Segment breakdown not available.

SEZL
SEZL

Merchant And Partner Income$28.9M37%
Transaction Income$25.9M33%
Income From Other Services Late Payment Fees$20.5M26%
Other$2.9M4%

Related Comparisons